S. 1421 - Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
- Sponsor:
- Orrin G. Hatch
- Summary:
- A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes. (by CRS)
- Status:
- The bill has been referred to committee.
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
S. 1421 — 114th Congress (2015–2016)
- Summary
- A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes.
- Other Titles
- Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
- Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
- Sponsor
- Orrin G. Hatch
- Co-Sponsors
- Subjects
- Health
- Administrative remedies
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Food and Drug Administration (FDA)
- Government information and archives
- Intellectual property
- Prescription drugs
- Related Bills
- Major Actions
Introduced 5/21/2015 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 5/21/2015 5/21/2015 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. 5/21/2015 Introduced in Senate Number Sponsor Date Offered Status
Contributions
- November - December 2010 For $16,650 Against $0
- January - February 2011 For $89,900 Against $0
- March - April 2011 For $216,925 Against $0
- May - June 2011 For $161,395 Against $0
- July - August 2011 For $74,830 Against $0
- September - October 2011 For $179,531 Against $0
- November - December 2011 For $129,900 Against $0
- January - February 2012 For $77,261 Against $0
- March - April 2012 For $192,013 Against $0
- May - June 2012 For $135,764 Against $0
- July - August 2012 For $107,454 Against $0
- September - October 2012 For $330,571 Against $0
- November - December 2012 For $25,225 Against $0
- January - February 2013 For $62,654 Against $0
- March - April 2013 For $230,380 Against $0
- May - June 2013 For $224,983 Against $0
- July - August 2013 For $90,604 Against $0
- September - October 2013 For $107,054 Against $0
- November - December 2013 For $101,550 Against $0
- January - February 2014 For $60,999 Against $0
- March - April 2014 For $158,105 Against $0
- May - June 2014 For $264,112 Against $0
- July - August 2014 For $160,403 Against $0
- September - October 2014 For $292,302 Against $0
- November - December 2014 For $33,065 Against $0
- January - February 2015 For $81,709 Against $0
- March - April 2015 For $206,766 Against $0
- May - June 2015 For $170,787 Against $0
- July - August 2015 For $56,042 Against $0
- September - October 2015 For $142,701 Against $0
- November - December 2015 For $117,384 Against $0
- January - February 2016 For $69,923 Against $0
- March - April 2016 For $139,949 Against $0
- May - June 2016 For $227,523 Against $0
- July - August 2016 For $91,751 Against $0
- September - October 2016 For $90,459 Against $0
- November - December 2016 For $15,905 Against $0
Votes
Contributions data source: OpenSecrets.org